Modification of guinea pig lung anaphylaxis by central nervous system (CNS) perturbations.
Since several studies indicate that protection from lethal anaphylaxis is mediated by anterior hypothalamic (AH) lesions, we investigated the hypothesis that central nervous system perturbations can modify release of mediators from antigen-challenged sensitized lungs. Three types of perturbations were made in guinea pigs: AH perturbation (electrodes inserted and the current was applied), anterior hypothalamic sham (AS) (electrodes placed as in the AH group but no current was passed), and posterior hypothalamic (PH) perturbation (electrodes placed and the current was applied). A control group was sham operated (electrodes not inserted). Eleven days after the operation, guinea pigs receiving brain perturbations and half the control group were sensitized to the antigen ovalbumin. The other half of the control group received vehicle only (nonsensitized). Twenty-five days after this procedure, lungs were perfused in situ, and the outflows were collected before and after injection of antigen. The perfusates were assayed for immunoreactive prostaglandin and histamine, and the lungs were assayed for cAMP, guanosine monophosphate, and histamine. Release of mediators and changes in lung cyclic nucleotides after perfusion with antigen were significantly greater in all the antigen-sensitized compared to the nonsensitized animals. Within the anaphylactic groups, significant reductions in mediators and in cyclic nucleotides were found in the animals with perturbations of the AH region compared to the CO animals. The time course of mediator release was not altered. The results extend to the biochemical level, the observation that the perturbation of the AH region can markedly modify the anaphylactic response, and indicate that this effect may be due to altered release of mediators.
Leslie
C A
CA
Geriatric Research, Education, and Clinical Center, E. N. Rogers Memorial Hospital, Bedford, Mass.
Mathé
A A
AA
D000707:Anaphylaxis / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001921:Brain / Q000473:pathology / Q000503:physiopathology*; D006168:Guinea Pigs; D006636:Histamine Release; D007032:Hypothalamus, Anterior / Q000503:physiopathology; D007034:Hypothalamus, Posterior / Q000503:physiopathology; D008168:Lung / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D009929:Organ Size; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D013238:Stereotaxic Techniques
D001095:Arachidonic Acids; D016718:Arachidonic Acid; D010047:Ovalbumin